{
    "nctId": "NCT02984228",
    "officialTitle": "The Efficacy of Ultrasound Guided Glenohumeral Joint Injections of Platelet Rich Plasma (PRP) Versus Hyaluronic Acid (HA) in the Treatment of Glenohumeral Osteoarthritis: a Randomized, Double-blind Control Trial",
    "inclusionCriteria": "* English speaking/literate\n* Age 18-100 years\n* Visual analog score pain \\>= 5\n* Greater than or equal to 3 months of pain after onset of symptoms that has failed conservative treatments\n* Confirmation of glenohumeral OA via routine imaging (MRI and x-ray; must be recent and within the past year)\n* Transient relief of symptoms after diagnostic intra-articular injection into the glenohumeral joint\n* Must have minimum age of 18 Years\n* Must have maximum age of 100 Years",
    "exclusionCriteria": "* Non-English speaking/illiterate\n* Painful active, concurrent cervical spine conditions\n* Current non-steroidal anti-inflammatory drug (NSAID) use\n* History of taking coumadin or similar anticoagulant, have a known coagulopathy, bleeding dyscrasia, or platelet count \\< 150,000/cubic mm\n* Allergic reaction to poultry or previous viscosupplementation\n* Involved in workers' compensation or active litigation involving affected shoulder\n* Inability to refrain from NSAID use for 5 days prior to and 6 weeks after injection\n* History of corticosteroid injection to affected shoulder within the last 3 months\n* History of viscosupplementation or platelet-rich plasma to affected shoulder within the last 6 months\n* Presence of acute fracture\n* History of shoulder tumor\n* Known uncontrolled systemic illness (uncontrolled diabetes, human immunodeficiency virus, vasculitis, autoimmune/inflammatory disease)\n* Psychiatric and somatoform disorders"
}